Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer

Nat Rev Clin Oncol. 2009 Apr;6(4):191-2. doi: 10.1038/nrclinonc.2009.24.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Bone Density / drug effects*
  • Bone Density Conservation Agents / administration & dosage*
  • Breast Neoplasms / drug therapy
  • Chemotherapy, Adjuvant / adverse effects
  • Clinical Trials, Phase III as Topic
  • Diphosphonates / administration & dosage*
  • Female
  • Humans
  • Imidazoles / administration & dosage*
  • Osteoporosis / chemically induced
  • Osteoporosis / prevention & control*
  • Survival Analysis
  • Treatment Outcome
  • Women's Health
  • Zoledronic Acid

Substances

  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid